Our aim with this review is to provide practical advice and management support for nurses
and other healthcare practitioners in managing fluid retention in adults with right heart failure (…

Background The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the
first disease-specific instrument for pulmonary arterial hypertension (PAH) to assess patient-…

Experimental studies have suggested potential benefit of beta-blocker therapy in pulmonary
hypertension. However, it is uncertain whether a reduction in heart rate can be achieved …

Results Is Bisoprolol safe in patients with i-PAH? An average dose of 4.4±3.2 mg (0-10mg)
of Bisoprolol and 2.7±1.4 tablets placebo was achieved. There were no reported cases of …

In patients with idiopathic pulmonary arterial hypertension (iPAH), iron deficiency is common
and has been associated with reduced exercise capacity and worse survival. Previous …

While beta-blockers are considered contraindicated in pulmonary arterial hypertension (PAH),
the prognostic significance of sympathetic nervous system over-activity suggests a …

Heart rate (HR) at rest is an important marker of prognosis in heart failure, but has not been
addressed in pulmonary arterial hypertension (PAH). To determine the prognostic value of …

… Wagenaar, meanwhile, more or less tends to equate practice with narrative (once actors
succeed in formulating a good story about an intractable, contentious policy issue, for example, …

… The authors thank physician’s assistant Martha Wagenaar (BSc) for assisting in the patient
recruitment and specialist nurse Karin Taat (BSc) for assisting in data collection and analysis. …

… Martha is very welcoming and receives Jesus in her house. And Mary listens to the words the
Lord speaks. Now Martha is … The Lord had to rebuke Martha and to recommend Mary. She …